Facebook
X
LinkedIn
Forward
Advancements in HIV Care: Best Practices, Emerging Therapies, and Comprehensive Patient Management
Activity Description
This course will define current goals for eradication of HIV, explore best practices and current evidence-based treatment guidelines, and examine how the healthcare team can aid in overcoming barriers and improving outcomes in HIV care.
Target Audience
Learning Objectives
- Define HIV and current goals for eradication
- Analyze current guidelines and best practices in the treatment of HIV
- Examine the role of the healthcare team in overcoming barriers and ensuring optimal patient outcomes in HIV care
| Name | Role | Disclosure of Relevant Financial Relationships with Ineligible Company |
|---|---|---|
Kari Muskopf Occupational Therapist | Other licensed training | Planner | No relevant financial relationship(s) with ineligible companies to disclose |
Daniele Anina Pharmacist | Planner & Speaker | No relevant financial relationship(s) with ineligible companies to disclose |
Alison Sutton Pharmacist | Planner | No relevant financial relationship(s) with ineligible companies to disclose |
Katrina Tan Pharmacist | Planner | No relevant financial relationship(s) with ineligible companies to disclose |
Claire Lauber Nurse | Planner | No relevant financial relationship(s) with ineligible companies to disclose |
Anjum Kumbkarni Physician | Planner | No relevant financial relationship(s) with ineligible companies to disclose |
Katherine Quinlan Pharmacy Technician | Other non-licensed training | Planner | No relevant financial relationship(s) with ineligible companies to disclose |
Shelley Lathrop Social Worker | Planner | No relevant financial relationship(s) with ineligible companies to disclose |
Mandy Lin Other | Other non-licensed training | Planner | No relevant financial relationship(s) with ineligible companies to disclose |
Jason Carr Pharmacist | Independent Reviewer | No relevant financial relationship(s) with ineligible companies to disclose |
Disclosures of relevant financial relationships
In accordance with the Accreditation Council for Continuing Medical Education's (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, Centene Institute for Advanced Health Education (Centene Institute) requires all those in control of educational content to disclose their financial relationships with ineligible companies within the prior 24 months. Ineligible companies are defined by the ACCME as companies whose primary business is producing, marketing, selling, re-selling or distributing health care products used by or on patients. Individuals must disclose all financial relationships, regardless of the amount, with ineligible companies and regardless of their view of the relevance of the relationship to the education. Centene Institute ensures that the content is independent of commercial bias.
None of the Centene Institute staff members have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Universal Activity Number UAN JA4008309-0000-25-007-H02-P/T
Available Credit
- 0.75 ACPE Pharmacy
- 0.75 ACPE Technician
- 0.75 AMA PRA Category 1 Credit™
- 0.75 ANCC
- 0.75 Attendance/Participation
- 0.75 IPCE
Since CE boards may have changes in requirements, it is the responsibility of the attendee to verify with their boards if they accept the CEs being offered.
Required Hardware/software
Please ensure you are using the web-browser Chrome and disable any pop-up blocking software.